{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:37:00Z","timestamp":1792082220962,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T00:00:00Z","timestamp":1251849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1038\/npp.2009.99","type":"journal-article","created":{"date-parts":[[2009,9,2]],"date-time":"2009-09-02T14:03:12Z","timestamp":1251900192000},"page":"2625-2632","source":"Crossref","is-referenced-by-count":51,"title":["DSM-IV Depression with Atypical Features: Is It Valid?"],"prefix":"10.1038","volume":"34","author":[{"given":"Jonathan W","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic M","family":"Quitkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,2]]},"reference":[{"key":"BFnpp200999_CR1","unstructured":"American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. APA: Washington, DC."},{"key":"BFnpp200999_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00432878","volume":"234","author":"J Angst","year":"1984","unstructured":"Angst J, Dobler-MiKola A, Binder J (1984). The Zurich Study -- a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology. Eur Arch Psychiatry Neurol Sci 234: 13\u201320.","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"BFnpp200999_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-0327(02)00169-6","volume":"72","author":"J Angst","year":"2002","unstructured":"Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K (2002). Toward validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord 72: 125\u2013138.","journal-title":"J Affect Disord"},{"key":"BFnpp200999_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.mp.4000436","volume":"4","author":"H Anisman","year":"1999","unstructured":"Anisman H, Ravindran AV, Griffiths J, Merali Z (1999). Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4: 182\u2013188.","journal-title":"Mol Psychiatry"},{"key":"BFnpp200999_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0165-1781(85)90017-4","volume":"14","author":"GM Asnis","year":"1985","unstructured":"Asnis GM, Halbreich U, Rabinovich H, Ryan ND, Sachar EJ, Nelson B et al (1985). The cortisol response to desipramine in endogenous depressives and normal controls: preliminary findings. Psychiatry Res 14: 225\u2013233.","journal-title":"Psychiatry Res"},{"key":"BFnpp200999_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1176\/ajp.152.1.31","volume":"152","author":"GM Asnis","year":"1995","unstructured":"Asnis GM, McGinn LK, Sanderson WC (1995). Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 152: 31\u201336.","journal-title":"Am J Psychiatry"},{"key":"BFnpp200999_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/j.1552-4604.1997.tb04786.x","volume":"37","author":"JS Barrett","year":"1997","unstructured":"Barrett JS, Hochadel TJ, Morales RJ, Rohatagi S, DeWitt KE, Watson SK et al (1997). Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males. J Clin Pharmacol 37: 238\u2013247.","journal-title":"J Clin Pharmacol"},{"key":"BFnpp200999_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0165-1781(99)00035-9","volume":"86","author":"F Benazzi","year":"1999","unstructured":"Benazzi F (1999). Prevalence and clinical features of atypical depression in depressed outpatients: a 467-case study. Psychiatry Res 86: 259\u2013265.","journal-title":"Psychiatry Res"},{"key":"BFnpp200999_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1037\/0021-843X.98.2.177","volume":"98","author":"GE Bruder","year":"1989","unstructured":"Bruder GE, Quitkin FM, Stewart JW, Martin C, Voglmaier MM, Harrison WM (1989). Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes. J Abnorm Psychol 98: 177\u2013186.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp200999_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1037\/0021-843X.111.3.446","volume":"111","author":"GE Bruder","year":"2002","unstructured":"Bruder GE, Stewart JW, McGrath PJ, Ma GJ, Wexler BE, Quitkin FM (2002). Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces. J Abnorm Psychol 111: 446\u2013454.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp200999_CR11","volume-title":"SCL-90: Administration, Scoring and Procedures Manual-I for the R (revised) Version and Other Instruments of the Psychopathology Rating Scales Series","author":"LR Derogatis","year":"1977","unstructured":"Derogatis LR (1977). SCL-90: Administration, Scoring and Procedures Manual-I for the R (revised) Version and Other Instruments of the Psychopathology Rating Scales Series. Johns Hopkins University School of Medicine: Chicago."},{"key":"BFnpp200999_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00004583-200210000-00010","volume":"41","author":"GJ Emslie","year":"2002","unstructured":"Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E et al (2002). Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled randomized clinical trial. J Am Acad Child Adolesc Psychiatry 41: 1205\u20131215.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFnpp200999_CR13","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","volume":"54","author":"GJ Emslie","year":"1997","unstructured":"Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T et al (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54: 1031\u20131037.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0165-1781(03)00097-0","volume":"118","author":"F Fotiou","year":"2003","unstructured":"Fotiou F, Fountoulakis KN, Iacovides A, Kaprinis G (2003). Pattern-reversed visual evoked potentials in subtypes of major depression. Psychiatry Res 118: 259\u2013271.","journal-title":"Psychiatry Res"},{"key":"BFnpp200999_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.pnpbp.2004.01.006","volume":"28","author":"KN Fountoulakis","year":"2004","unstructured":"Fountoulakis KN, Iacovides A, Gerasimou G, Fotiou F, Ioannidou C, Bascialla F et al (2004). The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 28: 537\u2013546.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp200999_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00004583-199905000-00012","volume":"38","author":"B Geller","year":"1999","unstructured":"Geller B, Reising D, Leonard HL, Riddle MA, Walsh BT (1999). Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 38: 513\u2013516.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFnpp200999_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0006-3223(96)00312-5","volume":"42","author":"TD Geracioti Jr","year":"1997","unstructured":"Geracioti Jr TD, Loosen PT, Orth DN (1997). Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol Psychiatry 42: 165\u2013174.","journal-title":"Biol Psychiatry"},{"key":"BFnpp200999_CR18","unstructured":"Hazell P, O'Connell D, Heathcote D, Henry D (2002). Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev 1: Art. no.: CD002317."},{"key":"BFnpp200999_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0165-0327(93)90028-I","volume":"29","author":"W Heller","year":"1993","unstructured":"Heller W (1993). Gender differences in depression: perspectives from neuropsychology. J Affect Disord 29: 129\u2013143.","journal-title":"J Affect Disord"},{"key":"BFnpp200999_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1440-1614.2001.01026.x","volume":"36","author":"PR Joyce","year":"2002","unstructured":"Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM et al (2002). Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Aust N Z J Psychiatry 36: 384\u2013391.","journal-title":"Aust N Z J Psychiatry"},{"key":"BFnpp200999_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00004583-200107000-00010","volume":"40","author":"MB Keller","year":"2001","unstructured":"Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B et al (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 40: 762\u2013772.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFnpp200999_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700011016","volume":"19","author":"RE Kendell","year":"1989","unstructured":"Kendell RE (1989). Clinical validity. Psychol Med 19: 45\u201355.","journal-title":"Psychol Med"},{"key":"BFnpp200999_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/archpsyc.1996.01830050025004","volume":"53","author":"KS Kendler","year":"1996","unstructured":"Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53: 391\u2013399.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/archpsyc.1974.01760160005001","volume":"31","author":"DF Klein","year":"1974","unstructured":"Klein DF (1974). Endogenomorphic depression: a conceptual and terminological revision. Arch Gen Psychiatry 31: 447\u2013454.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR25","first-page":"203","volume-title":"Validity of Psychiatric Diagnosis","author":"DF Klein","year":"1989","unstructured":"Klein DF (1989). The pharmacological validation of psychiatric diagnosis. In: Robins L, Barrett J (eds). Validity of Psychiatric Diagnosis. Raven: New York. pp 203\u2013216."},{"key":"BFnpp200999_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/(SICI)1520-6394(1998)7:1<15::AID-DA3>3.0.CO;2-4","volume":"7","author":"RG Klein","year":"1998","unstructured":"Klein RG, Mannuzza S, Koplewicz HS, Tancer NK, Shah M, Liang V et al (1998). Adolescent depression: controlled desipramine treatment and atypical features. Depress Anxiety 7: 15\u201331.","journal-title":"Depress Anxiety"},{"issue":"Suppl","key":"BFnpp200999_CR27","first-page":"57","volume":"26","author":"A Korn","year":"1987","unstructured":"Korn A, Da Prada M, Raffesberg W, Allen S, Gasic S (1987). Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor. J Neural Transm 26 (Suppl): 57\u201371.","journal-title":"J Neural Transm"},{"key":"BFnpp200999_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0010-440X(96)90020-6","volume":"37","author":"RW Lam","year":"1996","unstructured":"Lam RW, Stewart JN (1996). The validity of atypical depression in DSM-IV. Compr Psychiatry 37: 375\u2013383.","journal-title":"Compr Psychiatry"},{"key":"BFnpp200999_CR29","doi-asserted-by":"publisher","first-page":"1290137","DOI":"10.1001\/archpsyc.1988.01800260037004","volume":"45","author":"MR Liebowitz","year":"1988","unstructured":"Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS et al (1988). Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45: 1290137.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR30","first-page":"149","volume":"33","author":"MW Mandoki","year":"1997","unstructured":"Mandoki MW, Tapia MR, Tapia MA, Sumner GS, Parker JL (1997). Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull 33: 149\u2013154.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp200999_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/archpsyc.60.8.817","volume":"60","author":"LS Matza","year":"2003","unstructured":"Matza LS, Revicki DA, Davidson JR, Stewart JW (2003). Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences. Arch Gen Psychiatry 60: 817\u2013826.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0165-1781(96)02781-3","volume":"60","author":"LK McGinn","year":"1996","unstructured":"McGinn LK, Asnis GM, Rubinson E (1996). Biological and clinical validation of atypical depression. Psychiatry Res 60: 191\u2013198.","journal-title":"Psychiatry Res"},{"key":"BFnpp200999_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.ajp.157.3.344","volume":"157","author":"PJ McGrath","year":"2000","unstructured":"McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF (2000). A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression. Am J Psychiatry 157: 344\u2013350.","journal-title":"Am J Psychiatry"},{"key":"BFnpp200999_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0006-3223(96)00029-7","volume":"40","author":"AA Nierenberg","year":"1996","unstructured":"Nierenberg AA, Pava JA, Clancy K, Rosenbaum FJ, Fava M (1996). Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry 40: 691\u2013696.","journal-title":"Biol Psychiatry"},{"key":"BFnpp200999_CR35","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1176\/appi.ajp.159.9.1470","volume":"159","author":"G Parker","year":"2002","unstructured":"Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D (2002). Atypical depression: a reappraisal. Am J Psychiatry 159: 1470\u20131479.","journal-title":"Am J Psychiatry"},{"key":"BFnpp200999_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0010-440X(98)90080-3","volume":"39","author":"G Perugi","year":"1998","unstructured":"Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A et al (1998). The high prevalence of \u2018soft\u2019 bipolar (II) features in atypical depression. Compr Psychiatry 39: 63\u201371.","journal-title":"Compr Psychiatry"},{"key":"BFnpp200999_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/archpsyc.59.1.70","volume":"59","author":"MA Posternak","year":"2002","unstructured":"Posternak MA, Zimmerman M (2002). Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry 59: 70\u201376.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR38","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archpsyc.1990.01810220051006","volume":"47","author":"FM Quitkin","year":"1990","unstructured":"Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG et al (1990). Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 47: 935\u2013941.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1176\/ajp.145.10.1322-b","volume":"145","author":"FM Quitkin","year":"1988","unstructured":"Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E et al (1988). Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145: 306\u2013311.","journal-title":"Am J Psychiatry"},{"key":"BFnpp200999_CR40","first-page":"239","volume-title":"DSM IV Sourcebook","author":"JG Rabkin","year":"1996","unstructured":"Rabkin JG, Stewart JW, Quitkin FM, McGrath PJ, Harrison WM, Klein DF (1996). Should atypical depression be included in DSM-IV? In: Widiger TA, Frances AJ, Pincus HA, Ross R, First MB, Davis WW (eds). DSM IV Sourcebook. American Psychiatric Association: Washington, DC. Vol. 2, pp 239\u2013260."},{"key":"BFnpp200999_CR41","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1176\/ajp.126.7.983","volume":"126","author":"E Robins","year":"1970","unstructured":"Robins E, Guze SB (1970). Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 126: 983\u2013987.","journal-title":"Am J Psychiatry"},{"key":"BFnpp200999_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0033-3182(60)73041-X","volume":"1","author":"W Sargant","year":"1960","unstructured":"Sargant W (1960). Some newer drugs in the treatment of depression and their relationship to other somatic treatments. Psychosomatics 1: 14\u201317.","journal-title":"Psychosomatics"},{"key":"BFnpp200999_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","volume":"35","author":"RL Spitzer","year":"1978","unstructured":"Spitzer RL, Endicott J, Robins E (1978). Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773\u2013782.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp200999_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/00004714-199812000-00002","volume":"18","author":"JW Stewart","year":"1998","unstructured":"Stewart JW, Garfinkel R, Nunes EV, Donovan S, Klein DF (1998). Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Clin Psychopharmacology 18: 429\u2013434.","journal-title":"J Clin Psychopharmacology"},{"key":"BFnpp200999_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0893-133X(01)00313-X","volume":"26","author":"JW Stewart","year":"2002","unstructured":"Stewart JW, McGrath PJ, Quitkin FM (2002). Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features? Neuropsychopharmacology 26: 237\u2013245.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp200999_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0193-953X(18)30161-8","volume":"16","author":"JW Stewart","year":"1993","unstructured":"Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM (1993). Atypical depression. A valid clinical entity? Psychiatr Clin North Am 16: 479\u2013495.","journal-title":"Psychiatr Clin North Am"},{"key":"BFnpp200999_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.chi.0000192250.38400.9e","volume":"45","author":"KD Wagner","year":"2006","unstructured":"Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K (2006). A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry 45: 280\u2013288.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFnpp200999_CR48","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(04)16043-1","volume":"363","author":"CJ Whittington","year":"2004","unstructured":"Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363: 1341\u20131345.","journal-title":"Lancet"},{"key":"BFnpp200999_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1073\/pnas.97.1.325","volume":"97","author":"ML Wong","year":"2000","unstructured":"Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P et al (2000). Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97: 325\u2013330.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp200999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp200999","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp200999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:21:31Z","timestamp":1684455691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp200999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,2]]},"references-count":49,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BFnpp200999"],"URL":"https:\/\/doi.org\/10.1038\/npp.2009.99","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,2]]}}}